Skip to content

PSA density calculator

The calculation, the 0.15 and 0.20 cut-offs and how PSA density works together with MRI.

Dr. Petronio Melo, urologistA reference in prostate cancer
CRM-SP 157.598 · RQE 70.275
Reviewed by Dr. Petronio Melo on November 17, 2026
Book a consultation
Drawing of the prostate seen from above next to a calculator with a blank display and the division key highlighted
On this page

Quick answer

PSA density is your PSA divided by the volume of your prostate. It corrects a simple problem: a large prostate makes more PSA, even without cancer.2 The cut-offs quoted most often are 0.15 and 0.20 ng/mL/cm³, and the higher the density, the higher the chance of significant cancer.1,3 In my practice, PSA density comes in after the MRI, as one of several parameters. The result from the calculator is something to bring to your consultation, and it does not decide on its own whether a biopsy is needed.

Do the calculation

You need two numbers: your total PSA, from the blood test, and your prostate volume, which is in the MRI or ultrasound report. If you have several PSA results, use the most recent one.

Your numbers stay in your browser. Nothing is sent, stored or saved in cookies, and everything is cleared when you close the page.

Your most recent blood test result. Example: 4.5
You will find it in the MRI or ultrasound report. Example: 40

Result

Enter your PSA and prostate volume, then tap Calculate.

The result is shown with two decimal places, as in the studies. For example, a PSA of 6 ng/mL and a 40 mL prostate give 0.15. The same PSA in a 60 mL prostate gives 0.10, and in a 25 mL prostate, 0.24. The PSA is the same in all three cases. What changes is the size of the gland producing it, and that is what density shows.

Where to find your prostate volume

The MRI report usually gives the volume. If it only gives the three measurements, the volume comes from the ellipsoid formula: length times width times height, times 0.52. This is the calculation PI-RADS, the system that standardizes how prostate MRI is read, uses to record the volume in the report.5

For example, 5 cm wide, 4 cm high and 4 cm long gives 5 × 4 × 4 × 0.52, about 42 mL.

Ultrasound also measures the volume, and the density calculation is the same. When a patient has both, I use the MRI volume. If your report does not give the volume, bring the scan to your consultation.

What 0.15 and 0.20 mean

A PSA density of 0.15 means 0.15 ng/mL of PSA for every cm³ of prostate. It was first described in 1992, in a study of 61 men. The average was 0.044 in benign prostates and 0.581 in cancer.2 Since then, the limits used most in studies sit between 0.10 and 0.15 for suspicion of cancer, and 0.20 appears as a cut-off in the European guideline's recommendations.1

These figures come from an analysis used by the European guideline, in men who had an MRI before their first biopsy:1,4

MRI and densityRisk of significant cancer
PI-RADS 1 or 2 and density below 0.103%
PI-RADS 1 or 2 and density above 0.2018%
PI-RADS 3 and density below 0.104%
PI-RADS 3 and density above 0.2029%

The same density carries different weight depending on the MRI score. That is why I never read PSA density on its own.

PSA density together with MRI

In a German study of 1,040 men, everyone had an MRI followed by a biopsy. When the MRI showed no suspicious lesion, the chance of having no significant cancer was 79%. With a density of 0.15 or less, it rose to 89%. The authors estimated that about 20% of unnecessary biopsies could be avoided.3

It works the other way too. In the same analysis as the table, 28% of men with a density below 0.10 had a PI-RADS 4 or 5 MRI, and 31% of them had significant cancer.4 A low density does not cancel out a suspicious lesion on MRI.

MRI has its limits as well. In the PROMIS study, it picked up 93% of significant cancers, but many areas flagged as suspicious had no significant cancer.6 The biopsy is still the test that confirms the diagnosis.

What can change the calculation

  • Prostate medications such as finasteride and dutasteride lower the PSA.1 I explain how to read the test in these cases in PSA in men taking finasteride or dutasteride.
  • A PSA raised by recent ejaculation, cycling, infection or a rectal exam changes the result. The main factors are covered in what affects PSA.
  • PSA varies from one test to the next. The European guideline recommends repeating the PSA when it is between 3 and 10 ng/mL, before other tests.1 That is why it pays to look at the series of results over time.
  • Use a PSA and a volume from tests done around the same time. If your MRI is several years old, also bring your most recent ultrasound report, if you have one.

How I approach it

In my practice, I do not order free PSA routinely, and I do not use PSA density before the MRI. When the PSA is abnormal, I go straight to a prostate MRI, which also measures the volume.

After the MRI, I always look at the density. With PI-RADS 1 or 2, it is one of the parameters I use, though not the only one: I look at everything about the patient before deciding on a biopsy. With PI-RADS 3 or higher, I always recommend a transperineal biopsy, done under sedation. The MRI scores are explained in MRI and PI-RADS, and free PSA and the other markers in free PSA and PSA density.

When to see a urologist

  • If your PSA is abnormal, even without symptoms
  • If your MRI report shows PI-RADS 3, 4 or 5
  • If the density you calculated here is 0.15 or higher
  • If your PSA rises from one test to the next

Bring your MRI report, your earlier PSA results and the result of this calculation to the consultation. It can be in person, at my office in Vila Mariana, or online, in English, with your tests sent in advance, which also works if you live outside Brazil.

Send your case

If you would like my opinion on your PSA and MRI before a consultation, fill in the form below. You can tap the button under the calculator result to add the numbers. The form goes to my office, and you will get a reply within 24 hours by email or WhatsApp. It does not replace a consultation: it helps plan the next step.

Frequently asked questions

How is PSA density calculated?

You divide the PSA, in ng/mL, by the prostate volume, in mL or cm³, measured on an imaging test.2 A PSA of 6 ng/mL in a 40 mL prostate gives 0.15 ng/mL/cm³. The higher the density, the higher the chance of significant cancer.1

Which volume should I use, MRI or ultrasound?

The calculation is the same with either. When a patient has an MRI, I use the volume it measures, because PSA density comes into my assessment after the MRI. The report gives the volume in mL or cm³, which are the same unit.

Is a PSA density of 0.15 high?

It is one of the most widely used cut-offs. In a study of 1,040 men whose MRI showed no suspicious lesion, the chance of having no significant cancer rose from 79% to 89% when the density was 0.15 or less.3 Above that the risk is higher, but the number alone neither confirms nor rules out cancer.

What does a PSA density above 0.20 mean?

That the risk of significant cancer is higher. With an MRI showing no suspicious lesion and a density above 0.20, the risk was 18% in an analysis used by the European guideline, against 3% with a density below 0.10.1,4 The guideline notes that when suspicion stays high despite a negative MRI, a systematic biopsy is still needed.1

Does a low PSA density mean no biopsy?

Not on its own. The European guideline accepts omitting the biopsy and monitoring the PSA when PI-RADS is 2 or lower, the density is below 0.20 and there is no family history of prostate cancer, as a weak recommendation for shared decision-making.1 In my practice, with PI-RADS 3 or higher, I always recommend a biopsy. With PI-RADS 1 or 2, density is one of the parameters, and I look at the whole picture before deciding.

Does finasteride change PSA density?

Yes. Finasteride and dutasteride lower the PSA, so the calculation done with the measured value in a man taking them comes out lower.1 I explain how to read the PSA in these cases on the page about PSA and finasteride.

Should I calculate the density before having an MRI?

In my practice, no. When the PSA is abnormal, I go straight to a prostate MRI, which also measures the volume. The European guideline places MRI as the first tool for deciding on a biopsy, with a strong recommendation.1

Are the numbers I enter stored?

No. The calculation runs in your browser. Nothing is sent, stored or saved in cookies, and everything is cleared when you close the page.

Who can review PSA density results in São Paulo?

I see men with an abnormal PSA in São Paulo. I am Dr. Petronio Melo, a urologist and robotic surgeon, CRM-SP 157.598 and RQE 70.275. I hold a PhD from the University of São Paulo Medical School, with award-winning research on artificial intelligence in prostate cancer diagnosis, and I have performed more than 1,500 robotic and laparoscopic surgeries, more than 500 of them robotic. When the PSA is abnormal, I order a prostate MRI and, with PI-RADS 3 or higher, I recommend a transperineal biopsy, always under sedation. My office is in Vila Mariana, and the first consultation can be in person or online, in English.

References

  1. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. European Association of Urology; 2026. EAU
  2. Benson MC, Whang IS, Pantuck A, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol. 1992;147(3 Pt 2):815-816. PubMed
  3. Distler FA, Radtke JP, Bonekamp D, et al. The value of PSA density in combination with PI-RADS for the accuracy of prostate cancer prediction. J Urol. 2017;198(3):575-582. PubMed
  4. Schoots IG, Padhani AR. Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. BJU Int. 2021;127(2):175-178. PubMed
  5. Turkbey B, Rosenkrantz AB, Haider MA, et al. Prostate Imaging Reporting and Data System version 2.1: 2019 update of Prostate Imaging Reporting and Data System version 2. Eur Urol. 2019;76(3):340-351. PubMed
  6. Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389(10071):815-822. PubMed

Would you like to talk about your case?

In the consultation, I go over your tests and your priorities.

Book a consultation5.0186 Google reviews

Related guides